Semaglutide GLP-1 also improves insulin sensitivity, reduces inflammation, and encourages increased physical activityall vital components in managing a healthy weight
On the other hand, the clinical trials on semaglutide (Wegovy) for weight loss have been clear: On average, people taking that medication lose 15% of their body weight over 68 weeks compared to 2.4% of body weight in those taking a placebo
For comprehensive food guides, see best foods to eat on semaglutide , what to eat on tirzepatide , and foods to avoid on semaglutide
To fully understand how these treatments affect body weight, further research is needed
Formulation studies and those on the synthesis of cannabinoid derivatives have flourished in recent years, although only preclinical evidence has been reported
This is about education and the effects GLP-1 use is having on your brand